JACOBS LEVY EQUITY MANAGEMENT, INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$888,000
+44.4%
33,5000.0%0.01%
+33.3%
Q1 2019$615,000
+47.8%
33,5000.0%0.01%
+28.6%
Q4 2018$416,000
-35.2%
33,5000.0%0.01%
-22.2%
Q3 2018$642,000
+40.8%
33,5000.0%0.01%
+28.6%
Q2 2018$456,000
+88.4%
33,5000.0%0.01%
+75.0%
Q1 2018$242,000
+69.2%
33,500
-13.9%
0.00%
+33.3%
Q4 2017$143,00038,9000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders